NIH funds effort to test potential of abandoned meds

06/18/2013 | Forbes

Nine academic groups will receive $12.7 million from the NIH to test the potential of abandoned experimental treatments for diseases such as schizophrenia, Duchenne muscular dystrophy and Alzheimer's. Development of the drugs previously was ended over issues concerning efficacy, safety or market potential.

View Full Article in:

Forbes

Published in Briefs: